CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- REGDEX Other REGDEX
- 8-K Event Material agreement
- 4 Open-market buy President bought 11,800 shares at an average $6.71 ($79,191)
- 4 Open-market buy Chief Financial Officer bought 15,000 shares at an average $6.69 ($100,310)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Open-market buy 10% owner bought 1,000,000 shares at $6.00 ($6,000,000)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- 4 Option exercise Director acquired 11,000 shares (option exercise)
- 4 Option exercise Director acquired 14,000 shares (option exercise)
- 4 Option exercise Director acquired 21,000 shares (option exercise)
- 4 Option exercise Director acquired 19,000 shares (option exercise)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise Director acquired 25,000 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 53,190 shares at an average $8.34 ($443,782)
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 58 of 74 · 1,465 filings